These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 37445990)

  • 1. Exploring the Molecular Targets for the Antidepressant and Antisuicidal Effects of Ketamine Enantiomers by Using Network Pharmacology and Molecular Docking.
    Altê GA; Rodrigues ALS
    Pharmaceuticals (Basel); 2023 Jul; 16(7):. PubMed ID: 37513925
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suicide prevention and ketamine: insights from computational modeling.
    Charlton CE; Karvelis P; McIntyre RS; Diaconescu AO
    Front Psychiatry; 2023; 14():1214018. PubMed ID: 37457775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential Roles for the GluN2D NMDA Receptor Subunit in Schizophrenia.
    Vinnakota C; Hudson MR; Jones NC; Sundram S; Hill RA
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A role of splenic heme biosynthesis pathway in the persistent prophylactic actions of arketamine in lipopolysaccharide-treated mice.
    Ma L; Wang L; Qu Y; Wan X; Hashimoto K
    Transl Psychiatry; 2023 Jul; 13(1):269. PubMed ID: 37491335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Brain-Derived Neurotrophic Factor rs6265 polymorphism is associated with severe cancer-related fatigue and neuropathic pain in female cancer survivors.
    Goto T; Von Ah D; Li X; Xiang L; Kwiat C; Nguyen C; Hsiao CP; Saligan LN
    J Cancer Surviv; 2023 Jul; ():. PubMed ID: 37462904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction in Cognitive Symptoms Following Intranasal Esketamine Administration in Patients With Chronic Treatment-resistant Depression: A 12-Week Case Series.
    Pepe M; Bartolucci G; Marcelli I; Simonetti A; Camardese G; Di Nicola M; Sani G
    J Psychiatr Pract; 2023 Jul; 29(4):325-332. PubMed ID: 37449831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. BDNF Alterations in Brain Areas and the Neurocircuitry Involved in the Antidepressant Effects of Ketamine in Animal Models, Suggest the Existence of a Primary Circuit of Depression.
    Carboni E; Carta AR
    J Integr Neurosci; 2022 Aug; 21(5):144. PubMed ID: 36137960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional and Molecular Changes in the Prefrontal Cortex of the Chronic Mild Stress Rat Model of Depression and Modulation by Acute Ketamine.
    Mingardi J; Ndoj E; Bonifacino T; Misztak P; Bertoli M; La Via L; Torazza C; Russo I; Milanese M; Bonanno G; Popoli M; Barbon A; Musazzi L
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in neurotrophic signaling pathways in brain areas of the chronic mild stress rat model of depression as a signature of ketamine fast antidepressant response/non-response.
    Derosa S; Misztak P; Mingardi J; Mazzini G; Müller HK; Musazzi L
    Prog Neuropsychopharmacol Biol Psychiatry; 2024 Jan; 128():110871. PubMed ID: 37793481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modulation by chronic stress and ketamine of ionotropic AMPA/NMDA and metabotropic glutamate receptors in the rat hippocampus.
    Elhussiny MEA; Carini G; Mingardi J; Tornese P; Sala N; Bono F; Fiorentini C; La Via L; Popoli M; Musazzi L; Barbon A
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jan; 104():110033. PubMed ID: 32640261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase Mζ in medial prefrontal cortex mediates depressive-like behavior and antidepressant response.
    Yan W; Liu JF; Han Y; Zhang W; Luo YX; Xue YX; Zhu WL; Yang C; Chen WH; Guo HL; Ma YN; Yuan K; Wang JS; Shi J; Lu L
    Mol Psychiatry; 2018 Sep; 23(9):1878-1891. PubMed ID: 29180675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine.
    Jiang C; Lin WJ; Labonté B; Tamminga CA; Turecki G; Nestler EJ; Russo SJ; Salton SR
    Neuropsychopharmacology; 2019 Apr; 44(5):971-981. PubMed ID: 30504797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dopamine-Dependent Ketamine Modulation of Glutamatergic Synaptic Plasticity in the Prelimbic Cortex of Adult Rats Exposed to Acute Stress.
    Forti L; Ndoj E; Mingardi J; Secchi E; Bonifacino T; Schiavon E; Carini G; La Via L; Russo I; Milanese M; Gennarelli M; Bonanno G; Popoli M; Barbon A; Musazzi L
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antidepressant actions of ketamine and its enantiomers.
    Johnston JN; Henter ID; Zarate CA
    Pharmacol Ther; 2023 Jun; 246():108431. PubMed ID: 37146727
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bridging rapid and sustained antidepressant effects of ketamine.
    Kim JW; Suzuki K; Kavalali ET; Monteggia LM
    Trends Mol Med; 2023 May; 29(5):364-375. PubMed ID: 36907686
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.